SELL Fortis Healthcare — Manas Jaiswal, 25 Sept 2026

byManas JaiswalHorizon: NA (inferred Swing (≤2wk))25 Sept 2026via CNBC Awaaz.

Entry₹856.45Inferred

Target₹825

Stop loss₹871-1.70% risk

CMP₹837.8521h ago

Active+2.17%+1.53%upside left 13d left

Follow Manas Jaiswal for new calls(32% target hit, 323 closed calls)Get alerts Watch FORTIS for new buy/sell callsGet alerts See 311 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.

As of 26 Sept, 1:30 pm IST

5 supporting3 neutral5 opposing

Supports the SELL call (5)

MACD below its signal line — bearish momentum

Technicals · macd·26 Sept · today

How Delhi HC's Fortis Healthcare order makes listed firms answerable for promoters' personal debt

NewsLivemint·23 Sept · 2d ago

Fortis audit order could drag listed firms into promoters' personal debt cases: InGovern

NewsEt-Markets·22 Sept · 3d ago

Fortis Healthcare moves Supreme Court to stop forensic audit of IHH takeover

NewsCnbc-Tv18·16 Sept · 1w ago

Fortis Healthcare shares outlook by Nomura: Rating neutral and target price remains ₹1030 - check rationale

NewsLivemint·16 Sept · 1w ago

Neutral / worth noting (3)

Fortis Healthcare Ltd is disclosing information regarding a material litigation filed by Northern TK Venture Pte Ltd against Daiichi Sankyo Company, Limited before the Tokyo District Court in Japan. T

BSE · Company Update·25 Sept · today

How Delhi HC's Fortis Healthcare order safeguards investors, making listed firms answerable for promoters' personal debt

NewsLivemint·23 Sept · 2d ago

Fortis Healthcare Ltd is disclosing an update on a material litigation filed by its promoter shareholder, Northern TK Venture Pte Ltd (NTK), against Daiichi Sankyo Company, Limited in Japan. The discl

BSE · Company Update·11 Sept · 2w ago

Weighs against the SELL call (5)

RSI at 27 — oversold territory

Technicals · rsi·26 Sept · today

Fortis Healthcare signs 29-year pact for 400+ bed super speciality hospital in Delhi

NewsCnbc-Tv18·16 Sept · 1w ago

Fortis Healthcare has signed definitive agreements to provide healthcare services to a new 400+ bedded super specialty hospital in Ashok Vihar, New Delhi.

NSE · Press Release·16 Sept · 1w ago

Fortis Hospotel Limited, a subsidiary of Fortis Healthcare, has signed definitive agreements to provide healthcare services to a new 400+ bedded super specialty hospital in Ashok Vihar, New Delhi. The

BSE · Company Update·16 Sept · 1w ago

Fortis Hospotel Limited, a subsidiary of Fortis Healthcare, has signed definitive agreements with Seth Sunder Lal Jain Charitable Eye Hospital to provide healthcare services to a new 400+ bedded super

BSE · Company Update·16 Sept · 1w ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.